ABSTRACT Normal murine mammary epithelial cells possessed the capacity to bind epidermal growth factor (EGF) in a specific and saturable manner. Scatchard plot analysis showed a curvilinear pattern. Assuming that this is not due to negative cooperativity of EGF binding, the data suggest the presence of two classes of receptors with a high and a low affinity: Kd values = 1 X 10-10 M and 3.6 X 10' M, respectively. The number of highand low-affinity receptors was estimated to be 800 per cell and 8,600 per cell, respectively. The occupancy of EGF receptors for a half-maximal stimulation of DNA synthesis or inhibition of casein synthesis was about 10% and 6% of total receptors, respectively. A potent tumor promoter, 12-O-tetradecanoylphorbol 13-acetate, acted synergistically with EGF in terms of stimulation of DNA synthesis but not in terms of inhibition of casein synthesis when the two agents were added at a suboptimal concentration. The presence of the tumor promoter increased the amount of EGF bound to mammary cells in culture and also decreased a loss in the amount of EGF in the culture medium. These results indicate that mammary epithelial cells possess functional receptors for EGF, which are modulated by the tumor promoter.
Epidermal growth factor (EGF) is a single-chain polypeptide hormone produced and secreted by the salivary gland (1) , but its physiological function has not been fully established. It has been shown (2) that the level of an EGF-like substance in serum is elevated markedly during pregnancy when the mammary gland undergoes extensive cell proliferation and its ability to synthesize milk proteins is suppressed. Recently, we have found that EGF stimulates mammary cell proliferation and inhibits the synthesis of milk proteins casein and a-lactalbumin as well as the accumulation of milk protein mRNAs in a primary mouse mammary epithelial cell culture system (3) . Because EGF elicits its actions at physiological concentrations, we have postulated that EGF serves as a regulator for the growth and differentiation of mammary epithelial cells (3) . Because biological actions of EGF are thought to be mediated through specific high-affinity receptors on the plasma membrane (4) , it is important to demonstrate the presence of EGF receptors and to examine their properties in this system.
Earlier studies have indicated that some of the biological actions of EGF can be mimicked by 12-O-tetradecanoylphorbol 13 -acetate (TPA), a potent tumor promoter (5, 6) . Recently, we have shown that TPA, like EGF, stimulates mammary cell proliferation and inhibits differentiation in the cell culture system (7) . These findings prompted us to study the interaction between EGF and TPA in terms of the EGF receptors and biological actions on mammary epithelium.
In this paper, we describe the functional receptors specific for EGF in normal mammary epithelial cells and show that TPA synergizes with EGF to stimulate DNA synthesis by affecting the EGF receptor system.
MATERIALS AND METHODS
Materials were obtained as follows: 3H-labeled L amino acid mixture (1 mCi/ml; 1 Ci = 3.7 X 10'°Bq), [ (2) .
Primary Mammary Epithelial Cell Culture. C3H/HeN lactating mice, 3 to 5 days postpartum, were obtained from the Animal Breeding Facility, National Institutes of Health. Primary culture of mammary epithelium was performed by using attached collagen gels as described (3) . Briefly, epithelial cellenriched fractions obtained by collagenase digestion of mammary tissue were plated onto collagen gel-coated multi-well tissue culture plates (16 mm, diameter; Falcon) at a density of 1.0 X 105 cells per cm2. Each well contained 0.5 ml of medium 199 supplemented with 10% fetal bovine serum. Cells were incubated at 370C in humidified air with 5% CO2. After 24 hr, culture medium was replenished and cell culture was continued in medium containing 5% fetal bovine serum and indicated combinations of hormones. Cell culture was usually carried out for 4 days with a daily change of medium. The concentrations of hormones used were as follows: insulin, 5 pug/ml; prolactin [free of contaminating vasopressin and oxytocin (9) (Fig. 2) , whereas this process was inhibited by not greater than 10% by the following agents: fibroblast growth factor, multiplicationstimulating activity, and nerve growth factor (each at 1 ,ug/ml); platelet-derived growth factor (100 ,ug/ml); bovine prolactin and porcine insulin (each at 5 ,ug/ml); equine luteinizing hormone and porcine follicle-stimulating hormone (each at 1 international unit/ml).
Scatchard analysis of the cell-associated 125I-EGF binding showed an apparent curvilinear pattern (Fig. 2 Inset) . Assuming that this is not due to negative cooperativity of EGF binding, the data suggest the presence of two classes of EGF receptors with different affinities. By the use of a graphic analytical method for resolution of Scatchard plots (10), high-(Kd values = 1 x 10-10 M) and low-(Kd values = 3.6 X 10-9 M) affinity classes of receptors were detected. The number of high-and low-affinity receptors was estimated to be 800 per cell and 8,600 per cell, respectively. Fig. 3 shows the cell-associated EGF binding and biological activities in mammary epithelial cells as a function of EGF concentration. The cell population used was the same as that in the experiments in Fig. 2 . As reported previously (3), EGF stimulated DNA synthesis and inhibited casein synthesis at a concentration as low as 0.1 ng/ml, and its effect was maximal at 50-100 ng/ml. The ED50 values for stimulation of DNA synthesis and inhibition of casein synthesis were about 3 ng/ml and 1 ng/ ml, respectively. From the data in Fig. 3 , it was estimated that EGF exerted its biological-actions maximally when 78% of the total EGF receptor sites were occupied. However, only about 6-10% of occupancy was required for EGF to elicit a half-maximal response in terms of DNA synthesis or casein synthesis.
Previously, we have shown that TPA, like EGF, stimulates In our previous studies (3), it has been shown that the inhibitory effect of EGF on the synthesis of milk proteins is dissociable from its mitogenic action. This suggests the presence of different intracellular pathways of EGF actions leading to these two distinct biological events. The present findings, that synergism between EGF and TPA is only observed in terms of DNA synthesis but not of casein synthesis, are consistent with our previous interpretation. However, the question remains unanswered as to why EGF does not synergize with TPA to inhibit casein synthesis.
The data in Table 2 indicate that the presence of TPA increased the amount of 125I-EGF binding to mammary cells in culture by almost 3-fold. This increase can be accounted for, at least in part, by the elevated level of EGF in the medium contamiing TPA. At present, it is not known whether TPA also increases the number and affinity of EGF receptors. According to recent studies (17, 18) , EGF, after binding to its receptors, is internalized by the process of adsorptive endocytosis and delivered to lysosomes where it is degraded. This results in the inability of cells to rebind fresh EGF because of fewer exposed receptors, the event termed "down regulation." One possible explanation for the increase in EGF binding in the presence of TPA is that TPA prevented the down regulation of EGF receptors. However, our preliminary experiments indicate that down regulation of EGF receptors did not occur appreciably in the presence or absence of TPA (unpublished data).
The observed loss of EGF from the culture medium during culture is apparently mediated by intracellular degradation of EGF because no such a loss occurred in the absence of cells and no proteolytic activity was found in conditioned media. EGF degradation has been shown to be intimately coupled with binding and internalization (17, 18) . Accordingly, the change in EGF degradation may involve altered binding or internalization of EGF, or both. In short-term cultures, TPA was found to decrease EGF binding in mammary cells without affecting the ratio of`IL-EGF internalized to that bound to cell surface (unpublished data). Earlier studies by Lee and Weinstein (19) also showed that TPA exerts similar effects on various types of cells. Thus, it is possible that TPA decreases the degradation of EGF by decreasing EGF binding. This may be an important aspect of the ability of TPA to elicit synergistic action with EGF in this system as well. Such an action would spare the degradation of the growth factor in the cellular milieu and would be more significant when levels of growth factors are limiting. However, the possibility that TPA itself exerts some mitogenic activity by acting directly on pivotal processes associated with DNA synthesis to elicit synergistic action with EGF cannot be ruled out presently.
